Radioimmunoguided breast surgery using radiolabeled antibody nr-lu-10 fab: A pilot study

Tumori

Volumn 87, Issue 3, 2001, Pages 142-146

  Burak W E , Jr ^a   Depalatis, L ^a   Mosic, J L ^a   Soble, D ^a   Hinkle, G ^a   Hitchcock, C L ^a  

^a N914 Doan Hall ^*  (United States)

Author keywords

Breast cancer; NR LU 10; Radioimmunoguided

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; IODINE 125; MONOCLONAL ANTIBODY NR LU 10; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; GAMMA RADIATION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INTRAOPERATIVE PERIOD; ISOTOPE LABELING; MASTECTOMY; OCCULT CANCER; PARTIAL MASTECTOMY; PILOT STUDY; TUMOR LOCALIZATION;

EID: 0034939756     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160108700307     Document Type: Article

References (29)

1. Danish randomized trial comparing breast conservation therapy with mastectomy; six years of life-table analysis
2. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer
3. Mastectomy versus breast conserving therapy in the treatment of stage I and II carcinoma of the breast: A randomized trial at the National Cancer Institute
4. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer: EORTC 10801 trial
5. Breast conservation is the treatment of choice in small breast cancer: Long-term results of a randomized clinical trial
6. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy
7. Margin status and local recurrence after breast-conserving therapy
8. Late cosmetic outcome after conservative surgery and radiotherapy: Analysis of causes of cosmetic failure
9. Cosmetic evaluation of breast conserving treatment for mammary cancer: A quantitative analysis of the influence of radiation dose, fractionation, schedules, and surgical treatment techniques on cosmetic results
10. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma
11. Intraoperative detection of colorectal cancer with radioimmunoguided surgery and CC49, a second-generation monoclonal antibody
12. Successful experimental use of a self-contained gamma detecting device
13. Intra-abdominal recurrence of colorectal cancer detected by radioimmunoguided surgery (RIGS system)
14. Use of radioimmunoguided surgery after induction chemotherapy in locally advanced breast cancer
15. Staging of carcinoma of the breast using a hand-held gamma detecting probe and monoclonal antibody B72.3
16. Radioimmunoguided surgery after primary treatment of locally advanced breast cancer
17. Monoclonal antibodies to surface antigens of small cell carcinoma of the lung
18. Antigens associated with human lung adenocarcinoma defined by monoclonal antibodies
19. Identification of patients who are at high risk for locoregional breast cancer recurrence after conservative surgery and radiotherapy: A review article for surgeons, pathologists, and radiation and medical oncologists
20. Radioiodination, quality assessment, in vitro and in vivo stability of iodine-125 Nofetumomab
21. Biodistribution and localization of radiolabeled NR-LU-10 Fab fragment in human breast cancer xenografts
22. Conservative surgery for the management of invasive and noninvasive carcinoma of the breast
23. Ten year results of conservative surgery and irradiation for stage I and II breast cancer
24. Local recurrence after breast conserving surgery and radiotherapy
25. The role of frozen section analysis of margins during breast conservation surgery
26. Touch preparation cytology of breast lumpectomy margins with histologic correlation
27. Radioimmunolocalization of primary and metastatic breast cancer
28. Imaging of estrogen receptors in primary and metastatic breast cancer patients with iodine-123-labeled Z-MIVE
29. Overview of the current status of PET in breast cancer imaging